Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial.
Markowitz M, Frank I, Grant RM, Mayer KH, Elion R, Goldstein D, Fisher C, Sobieszczyk ME, Gallant JE, Van Tieu H, Weinberg W, Margolis DA, Hudson KJ, Stancil BS, Ford SL, Patel P, Gould E, Rinehart AR, Smith KY, Spreen WR. Markowitz M, et al. Among authors: van tieu h. Lancet HIV. 2017 Aug;4(8):e331-e340. doi: 10.1016/S2352-3018(17)30068-1. Epub 2017 May 22. Lancet HIV. 2017. PMID: 28546090 Clinical Trial.
Concomitant socioeconomic, behavioral, and biological factors associated with the disproportionate HIV infection burden among Black men who have sex with men in 6 U.S. cities.
Mayer KH, Wang L, Koblin B, Mannheimer S, Magnus M, del Rio C, Buchbinder S, Wilton L, Cummings V, Watson CC, Piwowar-Manning E, Gaydos C, Eshleman SH, Clarke W, Liu TY, Mao C, Griffith S, Wheeler D; HPTN061 Protocol Team. Mayer KH, et al. PLoS One. 2014 Jan 31;9(1):e87298. doi: 10.1371/journal.pone.0087298. eCollection 2014. PLoS One. 2014. PMID: 24498067 Free PMC article.
Infrequent HIV testing and late HIV diagnosis are common among a cohort of black men who have sex with men in 6 US cities.
Mannheimer SB, Wang L, Wilton L, Van Tieu H, Del Rio C, Buchbinder S, Fields S, Glick S, Connor MB, Cummings V, Eshleman SH, Koblin B, Mayer KH. Mannheimer SB, et al. Among authors: van tieu h. J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):438-45. doi: 10.1097/QAI.0000000000000334. J Acquir Immune Defic Syndr. 2014. PMID: 25197830 Free PMC article.
Sexual Behavior and Network Characteristics and Their Association with Bacterial Sexually Transmitted Infections among Black Men Who Have Sex with Men in the United States.
Scott HM, Irvin R, Wilton L, Van Tieu H, Watson C, Magnus M, Chen I, Gaydos C, Hussen SA, Mannheimer S, Mayer K, Hessol NA, Buchbinder S. Scott HM, et al. Among authors: van tieu h. PLoS One. 2015 Dec 31;10(12):e0146025. doi: 10.1371/journal.pone.0146025. eCollection 2015. PLoS One. 2015. PMID: 26720332 Free PMC article.
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
Mayer KH, Seaton KE, Huang Y, Grunenberg N, Isaacs A, Allen M, Ledgerwood JE, Frank I, Sobieszczyk ME, Baden LR, Rodriguez B, Van Tieu H, Tomaras GD, Deal A, Goodman D, Bailer RT, Ferrari G, Jensen R, Hural J, Graham BS, Mascola JR, Corey L, Montefiori DC; HVTN 104 Protocol Team; and the NIAID HIV Vaccine Trials Network. Mayer KH, et al. Among authors: van tieu h. PLoS Med. 2017 Nov 14;14(11):e1002435. doi: 10.1371/journal.pmed.1002435. eCollection 2017 Nov. PLoS Med. 2017. PMID: 29136037 Free PMC article. Clinical Trial.
Development and Validation of the Personalized Sexual Health Promotion (SexPro) HIV Risk Prediction Model for Men Who Have Sex with Men in the United States.
Scott H, Vittinghoff E, Irvin R, Liu A, Nelson L, Del Rio C, Magnus M, Mannheimer S, Fields S, Van Tieu H, Kuo I, Shoptaw S, Grinsztejn B, Sanchez J, Wakefield S, Fuchs JD, Wheeler D, Mayer KH, Koblin BA, Buchbinder S. Scott H, et al. Among authors: van tieu h. AIDS Behav. 2020 Jan;24(1):274-283. doi: 10.1007/s10461-019-02616-3. AIDS Behav. 2020. PMID: 31352633 Free PMC article.
Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial.
Kallas EG, Grunenberg NA, Yu C, Manso B, Pantaleo G, Casapia M, Baden LR, Valencia J, Sobieszczyk M, Van Tieu H, Allen M, Hural J, Graham BS, Kublin J, Gilbert PB, Corey L, Goepfert PA, McElrath MJ, Johnson RP, Huang Y, Frahm N. Kallas EG, et al. Among authors: van tieu h. Sci Transl Med. 2019 Nov 20;11(519):eaaw1673. doi: 10.1126/scitranslmed.aaw1673. Sci Transl Med. 2019. PMID: 31748227 Free PMC article. Clinical Trial.
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study.
Baden LR, Stieh DJ, Sarnecki M, Walsh SR, Tomaras GD, Kublin JG, McElrath MJ, Alter G, Ferrari G, Montefiori D, Mann P, Nijs S, Callewaert K, Goepfert P, Edupuganti S, Karita E, Langedijk JP, Wegmann F, Corey L, Pau MG, Barouch DH, Schuitemaker H, Tomaka F; Traverse/HVTN 117/HPX2004 Study Team. Baden LR, et al. Lancet HIV. 2020 Oct;7(10):e688-e698. doi: 10.1016/S2352-3018(20)30229-0. Lancet HIV. 2020. PMID: 33010242 Free PMC article. Clinical Trial.
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.
Stieh DJ, Barouch DH, Comeaux C, Sarnecki M, Stephenson KE, Walsh SR, Sawant S, Heptinstall J, Tomaras GD, Kublin JG, McElrath MJ, Cohen KW, De Rosa SC, Alter G, Ferrari G, Montefiori D, Mann P, Nijs S, Callewaert K, Goepfert PA, Edupuganti S, Karita E, Seaman MS, Corey L, Baden LR, Pau MG, Schuitemaker H, Tomaka F; ASCENT/HVTN118/HPX2003 Study Team. Stieh DJ, et al. J Infect Dis. 2023 Apr 18;227(8):939-950. doi: 10.1093/infdis/jiac445. J Infect Dis. 2023. PMID: 36348617 Free PMC article. Clinical Trial.
27 results